Ads
related to: fda
Search results
FDA Panel Rejects MDMA Drug for PTSD
Medscape· 4 days agoA US Food and Drug Administration (FDA) expert panel has found that the benefits of the psychedelic midomafetamine (MDMA) in combination with psychological intervention for ...
FDA Advisors Give a Hearty Thumbs Up to a COVID Vaccine Based on the JN.1 Strain
MedPage Today· 4 days agoAn FDA advisory committee voted unanimously, 16-0, Wednesday to recommend that the COVID-19 vaccines...
FDA rescinds marketing ban on Juul vaping products
KTBS Shreveport· 2 days agoJuul said Thursday its products will remain on the market during scientific review. In 2022, the FDA issued a marketing ban on Juul products, including devices and tobacco ...
FDA rescinds marketing ban on Juul vaping products
KSBW Salinas· 2 days agoJuul said Thursday its products will remain on the market during scientific review. In 2022, the FDA issued a marketing ban on Juul products, including...
FDA Panel Rejects MDMA Treatment
newser· 4 days agoHistoric: FDA advisers have never before considered a Schedule I psychedelic drug for medical use. In addition, no new treatment for PTSD has been...
FDA sets panel review for IceCure's breast cancer treatment By Investing.com
Investing.com· 4 days agoThe U.S. Food and Drug Administration (FDA) is set to convene a Medical Device Advisory Committee...
FDA vaccine advisors expected to vote on new COVID-19 booster formula
ABC Action News Tampa Bay· 4 days agoThe FDA’s vaccine advisory committee is expected to meet Tuesday. It was postponed due to the...
FDA recinds order blocking Juul’s e-cigarette marketing
Consumer Affairs· 2 days agoThe U.S. Food and Drug Administration (FDA) has done an about face, recinding its marketing denial...
FDA Rescinds Juul Ban, Opening Door for Federal Clearance
The Wall Street Journal· 2 days agoThe agency hasn’t yet reached a final determination on whether they can stay on the U.S. market, but...
FDA analysis raises no major concerns about Eli Lilly Alzheimer's drug
KSL Salt Lake City· 3 days agoAn FDA analysis of trial data for Eli Lilly's experimental Alzheimer's drug donanemab released on...
